Chad M McCall
Overview
Explore the profile of Chad M McCall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Obiorah I, McCall C, Balmaceda A, Salansky S, Agarwal A, Pozdnyakova O
Arch Pathol Lab Med
. 2025 Jan;
PMID: 39799968
Context.—: The College of American Pathologists Hematology and Clinical Microscopy Committee implemented a hemoglobinopathy proficiency testing and education program to monitor and assess the performance of participating laboratories. Objective.—: To...
2.
Han J, McCall C, Isom S, Smith W, Begley S, Jenneman D, et al.
Leuk Lymphoma
. 2024 Oct;
66(2):325-328.
PMID: 39411845
No abstract available.
3.
Zhao X, McCall C, Block J, Ondrejka S, Thakral B, Wang S, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Aug;
24(11):e808-e818.
PMID: 39089930
Background: Aggressive NK/T-Cell neoplasms are rare hematological malignancies characterized by the abnormal proliferation of NK or NK-like T (NK/T) cells. CD6 is a transmembrane signal transducing receptor involved in lymphocyte...
4.
Whiteley A, Ma D, Wang L, Yu S, Yin C, Price T, et al.
Science
. 2024 Jun;
384(6702):eadh5548.
PMID: 38900896
The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we...
5.
Atrash S, Robinson M, Taneja A, Paul B, Cassetta K, Ndiaye A, et al.
Eur J Haematol
. 2023 Jun;
111(3):373-381.
PMID: 37311695
Background: Ki-67 is an index of proliferative activity and is an established predictive and prognostic marker in multiple malignancies. However, its prognostic relevance in multiple myeloma (MM) is unclear. We...
6.
Hannah W, Ryan K, Pendyal S, Burrow T, Harley S, Cordell M, et al.
Am J Med Genet A
. 2022 Aug;
188(11):3364-3368.
PMID: 35972026
There is a broad differential diagnosis of infantile hepatosplenomegaly, with some etiologies being debilitating and treatable. A structured approach to history, examination, and laboratory and radiographic findings is important in...
7.
Babakoohi S, McCall C
Cureus
. 2022 Jul;
14(6):e25809.
PMID: 35822141
Dermatophytosis incognito can be missed in diagnosis, given its relatively low prevalence as compared with common cases of dermatophytosis and therefore, is likely under-reported. Cutaneous T-cell lymphoma (CTCL) is also...
8.
Halper-Stromberg E, McCall C, Haley L, Lin M, Vogt S, Gocke C, et al.
Clin Chem
. 2021 Sep;
67(11):1524-1533.
PMID: 34491318
Background: Clonal immunoglobulin and T-cell receptor rearrangements serve as tumor-specific markers that have become mainstays of the diagnosis and monitoring of lymphoid malignancy. Next-generation sequencing (NGS) techniques targeting these loci...
9.
Fairchild A, McCall C, Oyekunle T, Niedzwiecki D, Champ C, McKinney M, et al.
Clin Lymphoma Myeloma Leuk
. 2021 Jan;
21(5):e464-e469.
PMID: 33487576
Purpose: Diagnosing primary mediastinal (thymic) large B-cell lymphoma (PMBCL) is challenging because it is a clinicopathologic entity that shares characteristics with other lymphomas and lacks pathognomonic features. We sought to...
10.
Xian R, Xie Y, Haley L, Yonescu R, Pallavajjala A, Pittaluga S, et al.
Blood Cancer J
. 2020 Jun;
10(6):69.
PMID: 32555149
The diffuse variant of follicular lymphoma (dFL) is a rare variant of FL lacking t(14;18) that was first described in 2009. In this study, we use a comprehensive approach to...